Outpost Bio

Outpost Bio is a biotechnology company focused on making human microbiology computable to improve drug discovery and intervention outcomes. Headquartered in London and Boston, the company utilizes its proprietary 'Lab-in-the-Loop' platform, which integrates automated laboratory experimentation with advanced machine learning to decode the 'interaction layer' between microbial communities and human biology. By generating large-scale, human-derived functional datasets, Outpost Bio helps pharmaceutical and consumer health partners predict microbe-mediated metabolism, de-risk clinical development, and design safer, more effective formulations. The company recently emerged from stealth with a $3.5 million pre-seed funding round to advance its predictive models of the human microbiome.